1177 — Sino Biopharmaceutical Share News
0.000.00%
Last trade - 00:00- HK$98.09bn
- HK$101.92bn
- CNY31.83bn
Brief: Sino Biopharmaceutical Says Tqb3019 (Btk Protac) Approved For Clinical Trial By NMPA
Brief: Sino Biopharmaceutical Says Positive Results On Phase 3 Study Of Culmerciclib In Combination With Fulvestrant
Brief: Sino Biopharmaceutical Recommends Payment Of Final Dividend Of HK4 Cents Per Share
Brief: Sino Biopharmaceutical Enters Exclusive Cooperation Agreement With Delova Biotech For QP001
Brief: Sino Biopharmaceutical Signs Exclusive Strategic Cooperation Agreement With Sciwind Biosciences
Hong Kong stocks close firmer as Lunar New Year holiday kicks in
Brief: Sino Biopharmaceutical Says Positive Results From Phase III Study Of Benmelstobart Injection
Brief: Sino Biopharmaceutical Receives Approval For Marketing Benmelstobart Injection In Combination With Anlotinib Hydrochloride Capsule
Sino Biopharmaceutical rises most in nearly 5 weeks on LaNova deal
Brief: 中国生物制药斥1.4亿元取得禮新醫藥4.91%股權，就LM-108在中國大陸戰略合作
Brief: Sino Biopharmaceutical Signs Equity Investment And Strategic Cooperation Agreement
Brief: Sino Biopharmaceutical Says Approval Granted For EGFR Inhibitor "TQB3002"
Brief: Sino Biopharmaceutical Approval For Marketing Of Kras G12c Inhibitor Garsorasib Tablet From Nmpa
Brief: Sino Biopharmaceutical Says Acquisition Of 29.99% Equity Interest In Hob Biotech
Brief: Sino Biopharmaceutical Posts Qtrly Profit Attributable Of RMB1.15 Bln
Brief: Sino Biopharmaceutical Announces Exclusive License And Cooperation Deal With YZY Biopharma
Brief: Sino Biopharmaceutical Announces Interim Dividend Of HK3 Cents Per Share
Brief: Sino Biopharmaceutical Announces Acceptance Of New Drug Application
Sino Biopharm jumps on positive cancer drug trial results